Diarrhea Drug Abuse Shouldn't End OTC Sales, FDA Hears
Over-the-counter sales of Johnson & Johnson's diarrhea drug Imodium A-D shouldn't be halted despite an uptick in fatal overdoses, a top trade group told the U.S. Food and Drug Administration in...To view the full article, register now.
Already a subscriber? Click here to view full article